Isthmus Partners LLC Purchases Shares of 22,415 Cabot Corporation $CBT

Isthmus Partners LLC purchased a new position in Cabot Corporation (NYSE:CBTFree Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 22,415 shares of the specialty chemicals company’s stock, valued at approximately $1,486,000.

Other large investors have also modified their holdings of the company. Farther Finance Advisors LLC raised its stake in shares of Cabot by 9.6% in the fourth quarter. Farther Finance Advisors LLC now owns 1,873 shares of the specialty chemicals company’s stock valued at $124,000 after acquiring an additional 164 shares in the last quarter. Gabelli Funds LLC increased its holdings in Cabot by 1.3% during the 3rd quarter. Gabelli Funds LLC now owns 13,570 shares of the specialty chemicals company’s stock worth $1,032,000 after purchasing an additional 180 shares during the period. First Citizens Bank & Trust Co. increased its holdings in Cabot by 1.4% during the 3rd quarter. First Citizens Bank & Trust Co. now owns 14,558 shares of the specialty chemicals company’s stock worth $1,107,000 after purchasing an additional 206 shares during the period. Allworth Financial LP raised its position in Cabot by 22.4% in the 4th quarter. Allworth Financial LP now owns 1,455 shares of the specialty chemicals company’s stock valued at $96,000 after purchasing an additional 266 shares in the last quarter. Finally, Hantz Financial Services Inc. boosted its stake in shares of Cabot by 227.5% in the 3rd quarter. Hantz Financial Services Inc. now owns 429 shares of the specialty chemicals company’s stock valued at $33,000 after buying an additional 298 shares during the period. Hedge funds and other institutional investors own 93.18% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have recently commented on the company. Jefferies Financial Group reissued a “buy” rating and set a $85.00 price objective on shares of Cabot in a research report on Wednesday, February 4th. Wall Street Zen upgraded shares of Cabot from a “hold” rating to a “buy” rating in a research note on Saturday, May 9th. Zacks Research upgraded shares of Cabot from a “strong sell” rating to a “hold” rating in a report on Tuesday, January 27th. JPMorgan Chase & Co. increased their price objective on shares of Cabot from $68.00 to $70.00 and gave the company an “underweight” rating in a research report on Wednesday. Finally, Mizuho raised their price objective on shares of Cabot from $75.00 to $80.00 and gave the company a “neutral” rating in a report on Wednesday, May 6th. One research analyst has rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, Cabot currently has a consensus rating of “Hold” and an average price target of $80.25.

Get Our Latest Report on CBT

Cabot Trading Down 1.3%

NYSE:CBT opened at $81.04 on Friday. Cabot Corporation has a 1 year low of $58.33 and a 1 year high of $86.43. The stock has a market cap of $4.18 billion, a P/E ratio of 15.32, a P/E/G ratio of 10.74 and a beta of 0.78. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.96 and a current ratio of 1.45. The stock has a 50-day simple moving average of $74.88 and a 200-day simple moving average of $70.96.

Cabot (NYSE:CBTGet Free Report) last issued its earnings results on Tuesday, May 5th. The specialty chemicals company reported $1.61 earnings per share for the quarter, topping the consensus estimate of $1.47 by $0.14. Cabot had a return on equity of 21.33% and a net margin of 7.97%.The business had revenue of $904.00 million for the quarter, compared to analyst estimates of $900.31 million. During the same quarter last year, the company earned $1.90 EPS. The business’s quarterly revenue was down 3.4% on a year-over-year basis. Cabot has set its FY 2026 guidance at 6.000-6.50 EPS. As a group, analysts anticipate that Cabot Corporation will post 6.32 earnings per share for the current fiscal year.

Cabot Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, June 12th. Shareholders of record on Friday, May 29th will be paid a $0.4725 dividend. This is an increase from Cabot’s previous quarterly dividend of $0.45. This represents a $1.89 annualized dividend and a yield of 2.3%. The ex-dividend date is Friday, May 29th. Cabot’s payout ratio is currently 34.03%.

Cabot Profile

(Free Report)

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.

Featured Articles

Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Corporation (NYSE:CBTFree Report).

Institutional Ownership by Quarter for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.